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The Importance of Good Data, Analysis, 
and Interpretation for Showing the 
Economics of Reducing Healthcare-
Associated Infection 
To the Editor—In a recent review article in Infection Control 
and Hospital Epidemiology, Umscheid et al1 summarized pub-
lished data on incidence rates of catheter-associated blood-
stream infection (CABSI), catheter-associated urinary tract 
infection (CAUTI), surgical site infection (SSI), and venti-
lator-associated pneumonia (VAP); estimated how many cases 
are preventable; and calculated the savings in hospital costs 
and lives that would result from preventing all preventable 
cases. Providing these estimates to policy makers, political 
leaders, and health officials helps to galvanize their support 
for infection prevention programs. Our concern is that im-
portant limitations of the published studies on which Um-
scheid and colleagues built their findings are incompletely 
addressed in this review. More attention needs to be drawn 
to the techniques applied to generate these estimates. 
The ambitious goal of Umscheid and colleagues was to 
synthesize all evidence on the effectiveness of interventions 
to prevent CABSI, VAP, CAUTI, and SSI. The scope of this 
review might be too broad to allow a sufficiently detailed 
appraisal of the evidence found. Preventability is a moving 
target because technologies and behaviors change, and in-
ferences about causal effects depend on an explicit specifi-
cation of alternatives.2 Other evidence synthesis studies for 
infection control interventions have been narrower in scope 
and more cautious in interpreting the data. Gould et al3 reg-
istered a review of the effectiveness of hand hygiene inter-
ventions with the Cochrane Collaboration. Of 48 articles and 
1 thesis revealed by the search strategy, only 2 studies were 
included. The rest were excluded because they were small 
scale or poorly controlled or because their long-term impacts 
were not assessed. Some of the studies included by Umscheid 
et al that report infection control effectiveness had significant 
methodological flaws. Harris et al4 discuss the challenges that 
researchers face when trying to estimate the effectiveness of 
infection prevention. 
The information that Umscheid et al use to estimate the 
annual number of infections should be treated with caution. 
Large variability in the quality of infection surveillance data 
for CABSI was found by Lin et al.5 Whether other types of 
infection are surveyed with greater accuracy is unknown. 
None of the studies used to estimate the clinical and eco-
nomic consequences of these infections appropriately ac-
counted for length of stay or risk of death, either because the 
timing of infection was ignored altogether or because of con-
ditioning on the future.6 The consequence is that results are 
biased upward.7 Barnett et al8 showed that 11.23 extra days 
in the hospital were attributable to a case of healthcare-
associated infection when the timing of infection was ignored 
and that, when the timing of infection was appropriately 
included, the additional duration of hospital stay was reduced 
to 1.35 days. Problems of bias may also arise when attributing 
death risk to infection. 
Umscheid et al used cost data prepared by hospital ac-
countants to make an economic argument. This is inappro-
priate, because accountants and economists have different 
objectives and require different information.9 Accounting 
costs are unlikely to capture the opportunity cost of infec-
tions. The alternate use of resources released from reduced 
infection is easily misinterpreted when presented as cash sav-
ings to hospitals.10 
The findings of Umscheid et al1 were that between 23,545 
and 53,483 lives would be saved every year as a result of 
preventing preventable cases of CABSI, VAP, CAUTI, and SSI. 
Annual cost savings to hospitals would be between $3.43 
billion and $23.44 billion. Using a conservative estimate of 
$5.5 million per statistical life saved,11 the total economic 
benefit from eliminating preventable infections suggested to 
policy makers is between $136 billion and $341 billion an-
nually. We suggest that flaws in the underlying data used to 
make these estimates exaggerate the result and will improperly 
raise expectations about the value of future investments in 
prevention programs. A potential negative consequence for 
the infection control community is reduced credibility. An-
other risk associated with reporting such large numbers is 
that government health regulators might use them to justify 
withholding large cash reimbursements to hospitals when 
(preventable) infections do happen, and this might create an 
economic incentive to underreport infections,12 which is a 
quality-reducing activity. 
Relentless growth in healthcare costs means that decision 
makers will demand high-quality economic evidence prior to 
committing resources to healthcare programs. Reliable eco-
nomic arguments are important for obtaining extra resources 
and even for keeping existing ones. Those working toward 
reducing the number of infections should carefully craft eco-
nomic arguments on the basis of sound methods and good 
quality data,13 and they should use the evidence base to build 
sustainable and cost-effective infection control programs. 
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Reply to Graves et al 
To the Editor—We appreciate the interest by Graves et al1 
regarding our recent article estimating the proportion of 
healthcare-associated infections (HAIs) that are reasonably 
preventable and the related mortality and costs.2 In their let-
ter, Graves and colleagues suggest that our estimates were 
intended to galvanize support for infection prevention pro-
grams and were generated using studies with important lim-
itations. We wish to address these concerns in this response. 
Our analysis was originally performed in 2008 for the So-
ciety for Healthcare Epidemiology of America (SHEA), to be 
included in its written testimony on HAIs to Congress.3 To 
inform its testimony, SHEA requested that we review the 
published literature to estimate the proportion of HAIs that 
might be preventable. This was a critical question, because 
the federal government was considering a policy of nonpay-
ment for HAIs as an incentive to reduce HAIs.4 Although 
some believed this was an effective strategy to reduce HAIs, 
others were concerned that not all HAIs were preventable 
and that the incentive under consideration would present 
challenges to hospitals caring for patients at high risk for 
HAIs.5 To estimate the proportion of preventable HAIs in the 
most efficient and accurate manner, we used an up-to-date 
federally funded systematic review that examined the effec-
tiveness of single and multimodal interventions on HAI pre-
vention6 as well as the most recent and valid estimates of 
HAI incidence.7 We also conducted our own systematic review 
of studies examining the incremental costs of individual 
HAIs.2 The dilemma at the time was whether to make an 
estimate based on data of limited quality or to avoid making 
such an estimate because of the data limitations and take the 
chance that other estimates derived using a less scientific 
approach would inform the policy discussion. SHEA opted 
to inform the discussion with the best estimates available from 
the published literature, so the intent of our analysis and our 
subsequent article was to present those estimates while high-
lighting their key limitations and caveats. 
To ensure that we provided the most accurate and gen-
eralizable data on the effectiveness of HAI prevention inter-
ventions, we estimated ranges of preventability and included 
the lowest and highest risk reductions reported by only those 
studies that were conducted in the United States, were pub-
lished within the previous 10 years, and received a quality 
score of moderate or good from the federally sponsored sys-
tematic review.6 Of the 64 studies originally included in the 
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